Compounds > enzastaurin
Page last updated: 2024-09-05

enzastaurin and Long QT Syndrome

enzastaurin has been researched along with Long QT Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Darstein, CL; Lesimple, T; Musib, L; Ng, WT; Welch, PA1
Albert, PS; Duic, P; Fine, HA; Kim, L; Kotliarova, S; Kreisl, TN; Moore, K; Musib, L; Thornton, D; Walling, J1

Trials

2 trial(s) available for enzastaurin and Long QT Syndrome

ArticleYear
Effects of enzastaurin and its metabolites on the QT interval in cancer patients.
    Journal of clinical pharmacology, 2016, Volume: 56, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Electrocardiography; Female; Heart Rate; Humans; Indoles; Long QT Syndrome; Male; Middle Aged; Neoplasms

2016
A phase I trial of enzastaurin in patients with recurrent gliomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

    Topics: Adult; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Long QT Syndrome; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Phosphoproteins; Protein Kinase C; Protein Kinase C beta; Survival Analysis; Thrombocytopenia

2009